The steroid dexamethasone could potentially deter the growth of a prostate cancer subtype that was previously thought to be difficult to treat with medications, according to research by David Rickman and Olivier Elemento. Read more
Scott T. Tagawa, M.D., M.S., discusses the antibody-drug conjugate IMMU-132 for the treatment of patients with metastatic platinum-resistant urothelial cancer. Read more
Despite their nearness to death, a sizeable proportion of advanced cancer patients remain unaware of basic information about their illness or its treatment, according to Holly Prigerson, Ph.D. Read more
The rate at which genetically mutated cancer cells grow may help explain why patients with CLL develop resistance to ibrutinib, according to Dan Landau, M.D., Ph.D. Read more